ABSTRACT
Food security in a warming world is a grave concern for rapidly growing impoverished populations. Low-latitude inland fisheries provide protein for millions of rural poor, yet the impacts of high-frequency climate oscillations on these aquatic ecosystems are unknown. Here, we present a sub-annual-to-annual resolution paleolimnological reconstruction of upwelling, productivity, and algal composition at Lake Tanganyika, one of Africa's largest landlocked fisheries. The data reveal increases in diatom production at centennial-scale solar irradiance maxima, and interannual variability in upwelling linked to La Niña. Our study shows that interactions between global climatic controls and El Niño-Southern Oscillation teleconnections exert profound influences on the foundation of Lake Tanganyika's food web. Adapting long-term management practices to account for high-frequency changes in algal production will help safeguard inland fish resources.
ABSTRACT
BACKGROUND: Fish oil supplementation has been shown to delay spontaneous delivery, but the levels and clinical significance remain uncertain. We examined the association between plasma fatty acids quantified in pregnancy and subsequent risk of early preterm birth. METHODS: In a case-control design nested in the Danish National Birth Cohort, we identified 376 early preterm cases (<34 gestational weeks, excluding preeclampsia cases) and 348 random controls. Plasma eicosapentaenoic acid plus docosahexaenoic acid (EPA+DHA% of total fatty acids), were measured twice in pregnancy, at gestation weeks 9 and 25 (medians). Odds ratios and 95% confidence intervals (CI's) for associations between EPA+DHA and early preterm risk were estimated by logistic regression, adjusted for the woman's age, height, pre-pregnancy BMI, parity, smoking, and socioeconomic factors. Hypotheses and analytical plan were defined and archived a priori. FINDINGS: Analysis using restricted cubic splines of the mean of 1st and 2nd sample measurements showed a strong and significant non-linear association (pâ¯<â¯0.0001) in which the risk of early preterm birth steeply increased when EPA+DHA concentrations were lower than 2% and flattened out at higher levels. Women in the lowest quintile (EPA+DHAâ¯<â¯1.6%) had 10.27 times (95% confidence interval 6.80-15.79, pâ¯<â¯0.0001) increased risk, and women in the second lowest quintile had 2.86 (95% CI 1.79-4.59, pâ¯<â¯0.0001) times increased risk, when compared to women in the three aggregated highest quintiles (EPA+DHAâ¯≥â¯1.8%). INTERPRETATION: Low plasma concentration of EPA and DHA during pregnancy is a strong risk factor for subsequent early preterm birth in Danish women.
Subject(s)
Fatty Acids, Omega-3/blood , Premature Birth/blood , Adolescent , Adult , Case-Control Studies , Docosahexaenoic Acids/blood , Eicosapentaenoic Acid/analogs & derivatives , Eicosapentaenoic Acid/blood , Female , Humans , Middle Aged , Odds Ratio , Pregnancy , Risk Factors , Young AdultSubject(s)
Biodiversity , Lakes , Petroleum Pollution , Accidents , Animals , Cichlids , Food Supply , Humans , TanzaniaABSTRACT
Sotos syndrome (SS) represents an important human model system for the study of epigenetic regulation; it is an overgrowth/intellectual disability syndrome caused by mutations in a histone methyltransferase, NSD1. As layered epigenetic modifications are often interdependent, we propose that pathogenic NSD1 mutations have a genome-wide impact on the most stable epigenetic mark, DNA methylation (DNAm). By interrogating DNAm in SS patients, we identify a genome-wide, highly significant NSD1(+/-)-specific signature that differentiates pathogenic NSD1 mutations from controls, benign NSD1 variants and the clinically overlapping Weaver syndrome. Validation studies of independent cohorts of SS and controls assigned 100% of these samples correctly. This highly specific and sensitive NSD1(+/-) signature encompasses genes that function in cellular morphogenesis and neuronal differentiation, reflecting cardinal features of the SS phenotype. The identification of SS-specific genome-wide DNAm alterations will facilitate both the elucidation of the molecular pathophysiology of SS and the development of improved diagnostic testing.
Subject(s)
DNA Methylation/genetics , Genome, Human , Intracellular Signaling Peptides and Proteins/metabolism , Nuclear Proteins/metabolism , Sotos Syndrome/genetics , Gene Expression Regulation , Histone Methyltransferases , Histone-Lysine N-Methyltransferase , Humans , Intracellular Signaling Peptides and Proteins/genetics , Mutation , Nuclear Proteins/geneticsABSTRACT
Autism affects males more than females, giving rise to the idea that the influence of steroid hormones on early fetal brain development may be one important early biological risk factor. Utilizing the Danish Historic Birth Cohort and Danish Psychiatric Central Register, we identified all amniotic fluid samples of males born between 1993 and 1999 who later received ICD-10 (International Classification of Diseases, 10th Revision) diagnoses of autism, Asperger syndrome or PDD-NOS (pervasive developmental disorder not otherwise specified) (n=128) compared with matched typically developing controls. Concentration levels of Δ4 sex steroids (progesterone, 17α-hydroxy-progesterone, androstenedione and testosterone) and cortisol were measured with liquid chromatography tandem mass spectrometry. All hormones were positively associated with each other and principal component analysis confirmed that one generalized latent steroidogenic factor was driving much of the variation in the data. The autism group showed elevations across all hormones on this latent generalized steroidogenic factor (Cohen's d=0.37, P=0.0009) and this elevation was uniform across ICD-10 diagnostic label. These results provide the first direct evidence of elevated fetal steroidogenic activity in autism. Such elevations may be important as epigenetic fetal programming mechanisms and may interact with other important pathophysiological factors in autism.
Subject(s)
Asperger Syndrome/blood , Autistic Disorder/blood , Fetus/metabolism , Steroids/metabolism , Analysis of Variance , Case-Control Studies , Chromatography, Liquid , Cohort Studies , Denmark , Female , Gestational Age , Humans , Hydrocortisone/metabolism , Male , Principal Component Analysis , Tandem Mass SpectrometryABSTRACT
Human disease is rarely a matter of all or nothing; variable expressivity is generally observed. Part of this variability is explained by somatic mosaicism, which can arise by a myriad of genetic alterations. These can take place at any stage of development, possibly leading to unusual features visible at birth, but can also occur later in life, conceivably leading to cancer. Previously, detection of somatic mosaicism was extremely challenging, as many gold standard tests lacked the necessary resolution. However, with the advances in high-throughput sequencing, mosaicism is being detected more frequently and at lower levels. This raises the issue of normal variation within each individual vs mosaicism leading to disease, and how to distinguish between the two. In this article, we will define somatic mosaicism with a brief overview of its main mechanisms in concrete clinical examples, discuss the impact of next-generation sequencing technologies in its detection, and expand on the clinical implications associated with a discovery of somatic mosaicism in the clinic.
Subject(s)
Genetic Testing , Mosaicism , Aneuploidy , Chromosome Aberrations , Comparative Genomic Hybridization , Genetic Association Studies , Genetic Counseling , Genomics/methods , High-Throughput Nucleotide Sequencing , Humans , PhenotypeABSTRACT
Chronic paroxysmal hemicrania (CPH) is a rare primary headache syndrome, which is classified along with cluster headache and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) as a trigeminal autonomic cephalalgia. CPH is exquisitely responsive to indomethacin, so much so that the response is one of the current diagnostic criteria. The case of a patient with CPH, who had marked epigastric symptoms with indomethacin treatment and responded well to topiramate 150 mg daily, is reported. Cessation of topiramate caused return of episodes, and the response has persisted for 2 years. Topiramate may be a treatment option in CPH.
ABSTRACT
Our objective was to compare the presence of self-reported unilateral photophobia or phonophobia, or both, during headache attacks comparing patients with trigeminal autonomic cephalalgias (TACs)--including cluster headache, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and paroxysmal hemicrania--or hemicrania continua, and other headache types. We conducted a prospective study in patients attending a referral out-patient clinic over 5 months and those admitted for an intramuscular indomethacin test. Two hundred and six patients were included. In episodic migraine patients, two of 54 (4%) reported unilateral photophobia or phonophobia, or both. In chronic migraine patients, six of 48 (13%) complained of unilateral photophobia or phonophobia, or both, whereas none of the 24 patients with medication-overuse headache reported these unilateral symptoms, although these patients all had clinical symptoms suggesting the diagnosis of migraine. Only three of 22 patients (14%) suffering from new daily persistent headache (NDPH) experienced unilateral photophobia or phonophobia. In chronic cluster headache 10 of 21 patients (48%) had unilateral photophobia or phonophobia, or both, and this symptom appeared in four of five patients (80%) with episodic cluster headache. Unilateral photophobia or phonophobia, or both, were reported by six of 11 patients (55%) with hemicrania continua, five of nine (56%) with SUNCT, and four of six (67%) with chronic paroxysmal hemicrania. Unilateral phonophobia or photophobia, or both, are more frequent in TACs and hemicrania continua than in migraine and NDPH. The presence of these unilateral symptoms may be clinically useful in the differential diagnosis of primary headaches.
Subject(s)
Hyperacusis/epidemiology , Migraine Disorders/epidemiology , Photophobia/epidemiology , Risk Assessment/methods , Trigeminal Autonomic Cephalalgias/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Belgium/epidemiology , Comorbidity , Female , Humans , Hyperacusis/diagnosis , Incidence , Male , Middle Aged , Migraine Disorders/diagnosis , Photophobia/diagnosis , Risk Factors , Trigeminal Autonomic Cephalalgias/diagnosisABSTRACT
OBJECTIVE: Socioenvironmental stressors have been linked with increased symptom severity and relapse in those with schizophrenia. However, little is known about how individual differences in stress reactivity may contribute to these outcomes. METHOD: This study examined the association between the temperament characteristic of arousability and changes in negative affect and cardiovascular activity during a challenge task in 58 in-patients with diagnosis of schizophrenia and 21 controls. RESULTS: In the patient group, levels of arousability were significantly associated with increases in negative affect in response to the task and greater severity of affective symptoms. Levels of arousability were associated with decreased heart rate during the challenge task in our patient group. CONCLUSION: These findings suggest that greater attention be given to individual differences, such as temperament and personality characteristics, and their role in the experience of stressors, including emotional and physiological response, as well as symptom development.
Subject(s)
Arousal/physiology , Emotions/physiology , Psychotic Disorders/physiopathology , Schizophrenia/physiopathology , Schizophrenic Psychology , Adult , Attention/physiology , Autonomic Nervous System/physiopathology , Blood Pressure/physiology , Brief Psychiatric Rating Scale , Depression/diagnosis , Depression/physiopathology , Depression/psychology , Female , Heart Rate/physiology , Humans , Individuality , Male , Middle Aged , Problem Solving/physiology , Psychotic Disorders/diagnosis , Psychotic Disorders/psychology , Schizophrenia/diagnosis , Stress, Psychological/complications , TemperamentABSTRACT
Trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders, which are characterized by strictly unilateral pain, together with ipsilateral cranial autonomic symptoms. TACs include cluster headache (CH), paroxysmal hemicrania (PH) and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT syndrome). These diseases all have one thing in common: an activation of trigeminal nociceptive afferentia with a reflex-like activation of cranial autonomic efferentia via the facial nerve. TACs show differences not only in the length and frequency of attacks but also in the response to drug treatment. It is important to recognize and differentiate between these syndromes because they react very well, but very selectively to therapy.
Subject(s)
Trigeminal Autonomic Cephalalgias , Administration, Oral , Amines/therapeutic use , Analgesics/therapeutic use , Anesthetics, Local/administration & dosage , Anesthetics, Local/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cluster Headache/diagnosis , Cluster Headache/drug therapy , Cluster Headache/physiopathology , Cluster Headache/prevention & control , Cyclohexanecarboxylic Acids/therapeutic use , Diagnosis, Differential , Female , Fructose/analogs & derivatives , Fructose/therapeutic use , Gabapentin , Humans , Indomethacin/therapeutic use , Lamotrigine , Lidocaine/administration & dosage , Lidocaine/therapeutic use , Male , Methysergide/therapeutic use , Nociceptors/physiology , Oxygen Inhalation Therapy , Paroxysmal Hemicrania/diagnosis , Paroxysmal Hemicrania/physiopathology , Paroxysmal Hemicrania/prevention & control , SUNCT Syndrome/diagnosis , SUNCT Syndrome/drug therapy , SUNCT Syndrome/physiopathology , SUNCT Syndrome/prevention & control , Serotonin Antagonists/therapeutic use , Serotonin Receptor Agonists/administration & dosage , Serotonin Receptor Agonists/therapeutic use , Sumatriptan/administration & dosage , Sumatriptan/therapeutic use , Topiramate , Triazines/therapeutic use , Trigeminal Autonomic Cephalalgias/diagnosis , Trigeminal Autonomic Cephalalgias/drug therapy , Trigeminal Autonomic Cephalalgias/physiopathology , Trigeminal Autonomic Cephalalgias/prevention & control , Trigeminal Nerve/physiopathology , Vasoconstrictor Agents/administration & dosage , Vasoconstrictor Agents/therapeutic use , Vasodilator Agents/therapeutic use , Verapamil/therapeutic use , gamma-Aminobutyric Acid/therapeutic useABSTRACT
Traumatic brain injury (TBI) causes selective hippocampal cell death which is believed to be associated with the cognitive impairment observed in both clinical and experimental settings. The endogenous neurotrophin-4/5 (NT-4/5), a TrkB ligand, has been shown to be neuroprotective for vulnerable CA3 pyramidal neurons after experimental brain injury. In this study, infusion of recombinant NT-4/5 increased survival of CA2/3 pyramidal neurons to 71% after lateral fluid percussion brain injury in rats, compared with 55% in vehicle-treated controls. The functional outcome of this NT-4/5-mediated neuroprotection was examined using three hippocampal-dependent behavioral tests. Injury-induced impairment was evident in all three tests, but interestingly, there was no treatment-related improvement in any of these measures. Similarly, injury-induced decreased excitability in the Schaffer collaterals was not affected by NT-4/5 treatment. We propose that a deeper understanding of the factors that link neuronal survival to recovery of function will be important for future studies of potentially therapeutic agents.
Subject(s)
Brain Injuries/drug therapy , Hippocampus/pathology , Nerve Growth Factors/therapeutic use , Neurons/drug effects , Neuroprotective Agents/therapeutic use , Animals , Association Learning/drug effects , Behavior, Animal/drug effects , Brain Injuries/pathology , Cell Count/methods , Disease Models, Animal , Dose-Response Relationship, Radiation , Electric Stimulation/methods , Evoked Potentials/drug effects , Evoked Potentials/radiation effects , Hippocampus/physiopathology , In Vitro Techniques , Male , Motor Activity/drug effects , Neurons/physiology , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects , Recovery of Function/physiology , Time FactorsABSTRACT
SUNCT (Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing) and SUNA (Short-lasting Unilateral Neuralgiform headache attacks with cranial Autonomic symptoms) are rare primary headache syndromes, classified as Trigeminal Autonomic Cephalalgias (TACs). Hypothalamic involvement in the TACs has been suggested by functional imaging data and clinically with deep brain stimulation. Fifty-two patients (43 SUNCT, 9 SUNA) were studied to determine the clinical phenotype of these conditions and response to medications. A functional imaging study explored activation of the posterior hypothalamus in attacks of SUNCT/SUNA. The clinical study characterised SUNCT and SUNA in terms of epidemiology, phenotype and clinical characteristics. Indomethacin is ineffective on single-blind testing. Intravenous lidocaine was effective in all cases. Open-label trails showed the effectiveness of lamotrigine, topiramate and gabapentin. On functional imaging there was hypothalamic activation bilaterally in 5/9 SUNCT patients, and contralaterally in two patients. Two SUNCT patients had ipsilateral negative activation. In SUNA the activation was bilaterally negative. There was no hypothalamic activation in a patient with SUNCT secondary to a brainstem lesion. The data suggests that there should be revised classification for SUNCT and SUNA, with an increased range of attack duration and frequency, cutaneous triggering of attacks, and a lack of refractory period. The concept of 'attack load' is introduced. The lack of response to indomethacin and the response to intravenous lidocaine, are useful in diagnostic and therapeutic terms, respectively. Preventive treatments include lamotrigine, gabapentin and topiramate. The role of hypothalamic involvement in SUNCT and SUNA as TACs is considered.
Subject(s)
Analgesics/administration & dosage , Hypothalamus, Posterior/physiopathology , Magnetic Resonance Imaging , SUNCT Syndrome , Amines/administration & dosage , Anesthetics, Local/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anticonvulsants/administration & dosage , Autonomic Nervous System Diseases/physiopathology , Cohort Studies , Conjunctiva , Cyclohexanecarboxylic Acids/administration & dosage , Fructose/administration & dosage , Fructose/analogs & derivatives , Functional Laterality , Gabapentin , Humans , Indomethacin/administration & dosage , Lamotrigine , Lidocaine/administration & dosage , Oxygen/therapeutic use , Pain Measurement , Phenotype , Prospective Studies , SUNCT Syndrome/classification , SUNCT Syndrome/drug therapy , SUNCT Syndrome/physiopathology , Tears , Topiramate , Triazines/administration & dosage , gamma-Aminobutyric Acid/administration & dosageABSTRACT
Chronic paroxysmal hemicrania (CPH) is a rare primary headache syndrome, which is classified along with cluster headache and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) as a trigeminal autonomic cephalalgia. CPH is exquisitely responsive to indomethacin so much so that the response is one of the current diagnostic criteria. The case of a patient with CPH, who had marked epigastric symptoms with indomethacin treatment and responded well to topiramate 150 mg daily, is reported. Cessation of topiramate caused return of episodes, and the response has persisted for 2 years. Topiramate may be a treatment option in CPH.
Subject(s)
Anticonvulsants/therapeutic use , Fructose/analogs & derivatives , Paroxysmal Hemicrania/drug therapy , Adult , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Facial Injuries/complications , Fructose/therapeutic use , Humans , Indomethacin/adverse effects , Indomethacin/therapeutic use , Male , Paroxysmal Hemicrania/etiology , Topiramate , Treatment OutcomeABSTRACT
A 44-year-old female with gabapentin-responsive supraorbital neuralgia is presented. She had pre- and post-treatment nociceptive-specific blink reflexes carried out which tracked the good clinical outcome from treatment. The results of the electrophysiological testing imply some central component to the pathophysiology of supra-orbital neuralgia.
Subject(s)
Blinking , Neuralgia/diagnosis , Neuralgia/drug therapy , Orbit/innervation , Reflex, Abnormal , Adult , Amines/therapeutic use , Analgesics/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cyclohexanecarboxylic Acids/therapeutic use , Female , Gabapentin , Humans , Naproxen/therapeutic use , Treatment Outcome , gamma-Aminobutyric Acid/therapeutic useABSTRACT
Traumatic brain injury (TBI) is a significant health issue that often causes enduring cognitive deficits, in particular memory dysfunction. The hippocampus, a structure crucial in learning and memory, is frequently damaged during TBI. Since long-term potentiation (LTP) is the leading cellular model underlying learning and memory, this study was undertaken to examine how injury affects area CA1 LTP in mice using lateral fluid percussion injury (FPI). Brain slices derived from FPI animals demonstrated an inability to induce LTP in area CA1 7 days postinjury. However, area CA1 long-term depression could be induced in neurons 7 days postinjury, demonstrating that some forms of synaptic plasticity can still be elicited. Using a multi-disciplined approach, potential mechanisms underlying the inability to induce and maintain area CA1 LTP were investigated. This study demonstrates that injury leads to significantly smaller N-methyl-D-aspartate potentials and glutamate-induced excitatory currents, increased dendritic spine size, and decreased expression of alpha-calcium calmodulin kinase II. These findings may underlie the injury-induced lack of LTP and thus, contribute to cognitive impairments often associated with TBI. Furthermore, these results provide attractive sites for potential therapeutic intervention directed toward alleviating the devastating consequences of human TBI.
Subject(s)
Brain Injuries/complications , Brain Injuries/physiopathology , Hippocampus/physiopathology , Long-Term Potentiation , Memory Disorders/etiology , Memory Disorders/physiopathology , Animals , Brain Injuries/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Dendritic Spines/drug effects , Dendritic Spines/metabolism , Dendritic Spines/ultrastructure , Disease Models, Animal , Excitatory Postsynaptic Potentials/drug effects , Glutamic Acid/metabolism , Glutamic Acid/pharmacology , Hippocampus/metabolism , Long-Term Synaptic Depression , Memory Disorders/metabolism , Mice , Mice, Inbred C57BL , Neural Pathways/metabolism , Neural Pathways/physiopathology , Organ Culture Techniques , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/metabolism , Synaptic TransmissionABSTRACT
Paroxysmal hemicrania (PH) is a trigeminal autonomic cephalgia, characterised by unilateral attacks responsive to indomethacin. There are no published reports of a family history in PH. We report a mother and daughter both with PH. The daughter and her sister also had migraine.
Subject(s)
Family , Paroxysmal Hemicrania/diagnosis , Paroxysmal Hemicrania/genetics , Pedigree , Adult , Female , Genetic Predisposition to Disease/genetics , Heterozygote , Humans , Middle AgedABSTRACT
Cognitive deficits persist in patients who survive traumatic brain injury (TBI). Lateral fluid percussion brain injury in the mouse, a model of human TBI, results in hippocampal-dependent cognitive impairment, similar to retrograde amnesia often associated with TBI. To identify potential substrates of the cognitive impairment, we evaluated regional neuronal loss, regional hippocampal excitability and inhibitory synaptic transmission. Design-based stereology demonstrated an approximate 40% loss of neurons through all subregions of the hippocampus following injury compared with sham. Input/output curves recorded in slices of injured brain demonstrated increased net synaptic efficacy in the dentate gyrus in concert with decreased net synaptic efficacy and excitatory postsynaptic potential-spike relationship in area CA1 compared with sham slices. Pharmacological agents modulating inhibitory transmission partially restored regional injury-induced alterations in net synaptic efficacy. Both evoked and spontaneous miniature inhibitory postsynaptic currents (mIPSCs) recorded in surviving dentate granule neurons were smaller and less frequent in injured brains than in uninjured brains. Conversely, both evoked and spontaneous mIPSCs recorded in surviving area CA1 pyramidal neurons were larger in injured brains than in uninjured brains. Together, these alterations suggest that regional hippocampal function is altered in the injured brain. This study demonstrates for the first time that brain injury selectively disrupts hippocampal function by causing uniform neuronal loss, inhibitory synaptic dysfunction, and regional, but opposing, shifts in circuit excitability. These changes may contribute to the cognitive impairments that result from brain injury.
Subject(s)
Brain Injuries/complications , Brain Injuries/physiopathology , Cognition Disorders/etiology , Cognition Disorders/physiopathology , Hippocampus/physiopathology , Nerve Net/physiology , Afferent Pathways/physiology , Animals , Brain Injuries/pathology , Cognition Disorders/pathology , Dentate Gyrus/physiopathology , Electrophysiology , Excitatory Postsynaptic Potentials/physiology , Fear/physiology , Hippocampus/cytology , Male , Mice , Mice, Inbred C57BL , Nerve Net/cytology , Patch-Clamp Techniques , Synapses/physiologyABSTRACT
The separation of novel permanently charged oligomers was studied using paired-ion reversed-phase liquid chromatography. The polyionene studied is less than 5 kDa in size, but contains three oligomer series with different end-group chemistries. The complexity of this polyionene makes development of a single-dimension separation quite challenging. Separation under critical conditions was employed to fractionate the end-group conformations and then the chain length of the oligomers in each series was confirmed by LC-MS. The oligomers were then used to optimize a single-dimension HPLC separation. Precise modulation of the hydrophobicity of the ion-pair reagent and the stationary-phase chemistry yielded very high resolution one-dimensional separations.
Subject(s)
Polymers/chemistry , Pyridinium Compounds/chemistry , Quaternary Ammonium Compounds/chemistry , Chromatography, High Pressure Liquid , Mass SpectrometryABSTRACT
Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is a primary headache syndrome that has been reported to be resistant to treatment with intravenous lidocaine. We report four cases of SUNCT in whom intravenous lidocaine (1.3-3.3 mg kg(-1) h(-1)) completely suppressed the headaches for the duration of the infusion. The headache returned after cessation of treatment. Two patients went on to have their symptoms controlled on topiramate (50-300 mg daily). One patient had typical migrainous aura in association with some of the attacks of pain but never migrainous headaches. These cases suggest that treatment with lidocaine can be considered when acute intervention is required to suppress a severe exacerbation of SUNCT, and further broaden the therapeutic and clinical background of this syndrome.